ARCHIMED
Michael Sneijers is a seasoned finance professional with extensive experience in healthcare investment and entrepreneurship. Currently serving as Principal, Director, Associate Director, and Senior Associate at ARCHIMED since January 2018, Michael has also held the role of Adjunct Professor in financial entrepreneurship at IE University since July 2021. In addition to board positions at Aliri and CLEAN BIOLOGICS, Michael previously worked as Dealflow Manager and Senior Investment Manager at PMV, where responsibilities included guiding investment processes and managing funds. Earlier experience includes roles at ING as a Leveraged Finance Analyst and Deloitte as a Senior Auditor. Michael's academic credentials include an Executive MBA from IE Business School and master's degrees in Applied Economics and International Finance and Taxation.
This person is not in any teams
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.